News


September 25, 2021

French Chamber of Commerce and Industry: Digitalisierung in der Pharmaindustrie

We are looking forward to meeting French pharma companies during the partnering event organized by the French Chamber of Commerce and Industry from October 19 – […]
September 6, 2021

PharmAI at BIO-Europe Digital 2021

After a successful BIO-Europe Digital in spring, we are looking forward to the BIO-Europe Digital, October 26-29, 2021. During BIO-Europe, you have the opportunity to meet-up […]
August 6, 2021

European Biotech & Pharma Virtual Partnering Conference 2021

We are looking forward to the European Biotech & Pharma Virtual Partnering Conference, September 27-30, 2021. During the conference, we meet Japanese pharma companies and will […]
July 19, 2021

PharmAI GmbH is a member of Telekom TechBoost

We are proud that we could convince the TechBoost jury and acquired a long-term partner for hosting our SaaS infrastructure. As of July, we are a […]
May 6, 2021

PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA

There it is: An update on the PLIP NAR Nucleic Acids Research paper together with a fresh version of the PLIP web server. PLIP is probably the most […]
April 6, 2021

PharmAI at BIO Digital 2021

We are looking forward to the BIO Digital, June 14-18, 2021. During BIO, you have the opportunity to meet-up and discuss how PharmAI’s ground-breaking technology helps […]
March 1, 2021

PharmAI at BIO-Europe Spring Digital 2021

After a successful BIO-Europe Digital in autumn, we are looking forward to the BIO-Europe Spring Digital, March 22-25, 2021. During BIO-Europe Spring, we have the opportunity […]
September 18, 2020

PharmAI at BIO-Europe Digital 2020

Meet us to hear more about our scaffold diversification technique and how we can accelerate your drug discovery process.
September 1, 2020

New Off-Target Analysis Service

PharmAI provides now a unique off-target screening service covering 95% of human proteome target.
May 26, 2020

PharmAI at BIO Digital 2020

Meet us to hear more about our scaffold diversification technique and how we can accelerate your drug discovery process.
April 27, 2020

Rapid Identification of Novel PDE2 Inhibitors

Rapid Identification of Novel PDE2 Inhibitors with in silico Driven Library Prioritization and MicroScale Thermophoresis In a joint effort, PharmAI GmbH and 2bind GmbH have identified […]
April 22, 2020

PharmAI Now Official Maintainer of PLIP

PharmAI takes over the maintenance of the Protein-Ligand Interaction Profiler (PLIP). PLIP, a command line tool and a web service for fully automated characterization of non-covalent […]
April 9, 2020

We welcome Chris to PharmAI

Chris is the main author of a very sophisticated Java framework (github.com/singa-bio/) for various kinds of structural bioinformatics and systems biology. Prior to joining pharmAI, Chris […]
March 1, 2020

Agreement with Gero.ai

pharmAI and gero.ai sign a collaboration agreement. Gero LLC, an AI-powered platform and a drug pipeline for drug discovery and drug repurposing focused on complex diseases […]
November 7, 2019

Partnership with 2bind GmbH

Strategic partnership with 2bind - experts in biophysics
November 6, 2019

BIO-EUROPE 2019

pharmAI is attending BIO-EUROPE 2019 in Hamburg
Top